Aminoadamantanes as NMDA receptor antagonists and antiparkinsonian agents — preclinical studies
- 1 January 1997
- journal article
- review article
- Published by Elsevier in Neuroscience & Biobehavioral Reviews
- Vol. 21 (4), 455-468
- https://doi.org/10.1016/s0149-7634(96)00037-1
Abstract
No abstract availableKeywords
This publication has 118 references indexed in Scilit:
- Suppression by memantine and amantadine of synaptic excitation intrastriatally evoked in rat neostriatal slicesNeuroscience Letters, 1994
- Memantine, amantadine, and L-deprenyl potentiate the action of L-DOPA in monoamine-depleted ratsJournal of Neural Transmission, 1994
- The clinically available NMDA receptor antagonist memantine is antinociceptive on rat spinal neuronesNeuroReport, 1993
- Differential locomotor interactions between dopamine D1/D2 receptor agonists and the NMDA antagonist dizocilpine in monoamine-depleted miceJournal of Neural Transmission, 1992
- Comparative Effect of Transient Global Ischemia on Extracellular Levels of Glutamate, Glycine, and γ‐Aminobutyric Acid in Vulnerable and Nonvulnerable Brain Regions in the RatJournal of Neurochemistry, 1991
- Effects of the 1-amino-adamantanes at the MK-801-binding site of the NMDA-receptor-gated ion channel: a human postmortem brain studyEuropean Journal of Pharmacology: Molecular Pharmacology, 1991
- The NMDA antagonist MK-801 causes marked locomotor stimulation in monoamine-depleted miceJournal of Neural Transmission, 1989
- Memantine inhibits serotonin-induced rise of cytosolic Ca2+ activity and of cyclic GMP level in a neuronal cell lineEuropean Journal of Pharmacology: Molecular Pharmacology, 1989
- Amantadine may stimulate dopamine and noradrenaline receptorsNeuropharmacology, 1974
- Anticataleptic actions of amantadine hydroehlorideNaunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie, 1970